Issue 6/2007
Content (32 Articles)
The role of physical activity in the management of impaired glucose tolerance: a systematic review
T. Yates, K. Khunti, F. Bull, T. Gorely, M. J. Davies
Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes
V. Fonseca, A. Schweizer, D. Albrecht, M. A. Baron, I. Chang, S. Dejager
Intra-abdominal fat accumulation predicts the development of the metabolic syndrome in non-diabetic Japanese-Americans
J. Tong, E. J. Boyko, K. M. Utzschneider, M. J. McNeely, T. Hayashi, D. B. Carr, T. M. Wallace, S. Zraika, F. Gerchman, D. L. Leonetti, W. Y. Fujimoto, S. E. Kahn
Relationship between increased relative birthweight and infections during pregnancy in children with a high-risk diabetes HLA genotype
H. E. Larsson, K. Lynch, B. Lernmark, G. Hansson, Å. Lernmark, S.-A. Ivarsson
Diabetes, glycaemic control and mortality risk in patients on haemodialysis: the Japan Dialysis Outcomes and Practice Pattern Study
Y. Hayashino, S. Fukuhara, T. Akiba, T. Akizawa, Y. Asano, A. Saito, J. L. Bragg-Gresham, S. P. B. Ramirez, F. K. Port, K. Kurokawa
Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study
A. M. Brennan, T. Y. Li, I. Kelesidis, A. Gavrila, F. B. Hu, C. S. Mantzoros
TCF7L2 in the Go-DARTS study: evidence for a gene dose effect on both diabetes susceptibility and control of glucose levels
C. H. Kimber, A. S. F. Doney, E. R. Pearson, M. I. McCarthy, A. T. Hattersley, G. P. Leese, A. D. Morris, C. N. A. Palmer
Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion
J. Wang, J. Kuusisto, M. Vänttinen, T. Kuulasmaa, J. Lindström, J. Tuomilehto, M. Uusitupa, M. Laakso
Variation in the peroxisome proliferator-activated receptor δ gene in relation to common metabolic traits in 7,495 middle-aged white people
N. Grarup, A. Albrechtsen, J. Ek, K. Borch-Johnsen, T. Jørgensen, O. Schmitz, T. Hansen, O. Pedersen
Association testing of common variants in the insulin receptor substrate-1 gene (IRS1) with type 2 diabetes
J. C. Florez, M. Sjögren, C. M. Agapakis, N. P. Burtt, P. Almgren, U. Lindblad, G. Berglund, T. Tuomi, D. Gaudet, M. J. Daly, K. G. Ardlie, J. N. Hirschhorn, D. Altshuler, L. Groop
Genetic association of single nucleotide polymorphisms in endonuclease G-like 1 gene with type 2 diabetes in a Japanese population
M. Moritani, K. Nomura, T. Tanahashi, D. Osabe, Y. Fujita, S. Shinohara, Y. Yamaguchi, P. Keshavarz, E. Kudo, N. Nakamura, T. Yoshikawa, E. Ichiishi, Y. Takata, N. Yasui, H. Shiota, K. Kunika, H. Inoue, M. Itakura
Directed differentiation of human embryonic stem cells towards a pancreatic cell fate
J. H. Shim, S. E. Kim, D. H. Woo, S. K. Kim, C. H. Oh, R. McKay, J. H. Kim
Gene expression heterogeneity in human islet endocrine cells in vitro: the insulin signalling cascade
D. Muller, G. C. Huang, S. Amiel, P. M. Jones, S. J. Persaud
Cytokine-induced osteoprotegerin expression protects pancreatic beta cells through p38 mitogen-activated protein kinase signalling against cell death
J. Schrader, W. Rennekamp, U. Niebergall, M. Schoppet, H. Jahr, M. D. Brendel, D. Hörsch, L. C. Hofbauer
Pancreatic deletion of insulin receptor substrate 2 reduces beta and alpha cell mass and impairs glucose homeostasis in mice
J. Cantley, A. I. Choudhury, H. Asare-Anane, C. Selman, S. Lingard, H. Heffron, P. Herrera, S. J. Persaud, D. J. Withers
Improved vascular engraftment and function of autotransplanted pancreatic islets as a result of partial pancreatectomy in the mouse and rat
M. Johansson, L. Jansson, P.-O. Carlsson
C3H/HeJ mice carrying a toll-like receptor 4 mutation are protected against the development of insulin resistance in white adipose tissue in response to a high-fat diet
M. Poggi, D. Bastelica, P. Gual, M. A. Iglesias, T. Gremeaux, C. Knauf, F. Peiretti, M. Verdier, I. Juhan-Vague, J. F. Tanti, R. Burcelin, M. C. Alessi
Glucokinase activator PSN-GK1 displays enhanced antihyperglycaemic and insulinotropic actions
M. C. T. Fyfe, J. R. White, A. Taylor, R. Chatfield, E. Wargent, R. L. Printz, T. Sulpice, J. G. McCormack, M. J. Procter, C. Reynet, P. S. Widdowson, P. Wong-Kai-In
Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosis
M. Nieuwdorp, F. Holleman, E. de Groot, H. Vink, J. Gort, A. Kontush, M. J. Chapman, B. A. Hutten, C. B. Brouwer, J. B. L. Hoekstra, J. J. P. Kastelein, E. S. G. Stroes
Proteomic analysis of human vitreous fluid by fluorescence-based difference gel electrophoresis (DIGE): a new strategy for identifying potential candidates in the pathogenesis of proliferative diabetic retinopathy
M. García-Ramírez, F. Canals, C. Hernández, N. Colomé, C. Ferrer, E. Carrasco, J. García-Arumí, R. Simó
Human high-density lipoprotein particles prevent activation of the JNK pathway induced by human oxidised low-density lipoprotein particles in pancreatic beta cells
A. Abderrahmani, G. Niederhauser, D. Favre, S. Abdelli, M. Ferdaoussi, J. Y. Yang, R. Regazzi, C. Widmann, G. Waeber
Plasminogen activator inhibitor-1 production is pathogenetic in experimental murine diabetic renal disease
M. Lassila, K. Fukami, K. Jandeleit-Dahm, T. Semple, P. Carmeliet, M. E. Cooper, A. R. Kitching
Systemic and renal growth hormone–IGF1 axis involvement in a mouse model of type 2 diabetes
Y. Segev, R. Eshet, O. Yakir, N. Haim, M. Phillip, D. Landau
Enhanced activity of the myocardial Na+/H+ exchanger contributes to left ventricular hypertrophy in the Goto–Kakizaki rat model of type 2 diabetes: critical role of Akt
A. Darmellah, D. Baetz, F. Prunier, S. Tamareille, C. Rücker-Martin, D. Feuvray
The Pro12Ala polymorphism in PPARG2 increases the effectiveness of primary prevention of cardiovascular disease by a lifestyle intervention
K. Rittig, C. Thamer, F. Machicao, R. Rietig, N. Stefan, A. Fritsche, H.-U. Haring, B. Balletshofer
Modified end-stage renal disease risk score for Chinese type 2 diabetic patients—the Hong Kong Diabetes Registry
X. L. Yang, W. Y. So, A. P. S. Kong, C. S. Ho, C. W. K. Lam, M. H. L. Ng, R. R. Lyu, D. D. Yin, C. C. Chow, C. S. Cockram, P. C. Y. Tong, J. C. N. Chan
Comment on: Nathan DM, Buse JB, Davidson MB et al (2006) Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 49:1711–1721
G. Slama, B. Balkau, P. Valensi